GlobalData04.17.20
According to Dara Lo, medical device analyst at GlobalData, Baxter’s Q1 2020 earnings will increase above expected projections—at a time when most medical device companies are experiencing decreases and withdrawing their financial year 2020 guidance due to the negative industry impact of the COVID-19 pandemic.
Baxter manufactures life-saving blood purification systems regularly used in acute chronic and kidney conditions. The demand for these medical devices has surged due to the influx of COVID-19 patients requiring intensive care in hospitals.
Baxter’s job postings have nearly tripled between February and March 2020, which is in-line with the company experiencing a significant increase in demand.
Curious how medtech's top companies are responding to the COVID-19 pandemic? Get insights into each company's actions by clicking here.
In addition, all Baxter facilities are maximizing production levels and increasing access to air freight capacity, as well as the frequency of transporting devices and medicines between the US and Europe. This will aid the company in getting more of its products to hospitals as quickly as possible.
“Despite the US’ efforts to curb the spread of COVID-19, the country continues to lead in number of daily new cases, with six times the number of new cases over the second-leading country, Spain. These numbers indicate the high need for continued supply of essential, life-saving medical devices, such as the ones being produced by Baxter,” added Lo.
Baxter manufactures life-saving blood purification systems regularly used in acute chronic and kidney conditions. The demand for these medical devices has surged due to the influx of COVID-19 patients requiring intensive care in hospitals.
Baxter’s job postings have nearly tripled between February and March 2020, which is in-line with the company experiencing a significant increase in demand.
Curious how medtech's top companies are responding to the COVID-19 pandemic? Get insights into each company's actions by clicking here.
In addition, all Baxter facilities are maximizing production levels and increasing access to air freight capacity, as well as the frequency of transporting devices and medicines between the US and Europe. This will aid the company in getting more of its products to hospitals as quickly as possible.
“Despite the US’ efforts to curb the spread of COVID-19, the country continues to lead in number of daily new cases, with six times the number of new cases over the second-leading country, Spain. These numbers indicate the high need for continued supply of essential, life-saving medical devices, such as the ones being produced by Baxter,” added Lo.
